Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120437346 | 12043734 | 6 | F | 20150323 | 20160711 | 20160208 | 20160718 | EXP | BR-ROCHE-1550636 | ROCHE | 59.24 | YR | F | Y | 58.00000 | KG | 20160718 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120437346 | 12043734 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | LAST INFUSION ON 01/MAY/2016 | U | 81026801 | 125276 | SOLUTION FOR INFUSION | |||||||
120437346 | 12043734 | 2 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | |||||||||||
120437346 | 12043734 | 3 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
120437346 | 12043734 | 4 | C | MELOXICAM. | MELOXICAM | 1 | 0 | ||||||||||||
120437346 | 12043734 | 5 | C | PARACETAMOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
120437346 | 12043734 | 6 | C | NAPROXEN. | NAPROXEN | 1 | 0 | ||||||||||||
120437346 | 12043734 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 0 | 20 | MG | |||||||||
120437346 | 12043734 | 8 | C | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | 0 | 5 | MG | |||||||||
120437346 | 12043734 | 9 | C | FOLINA (FOLIC ACID) | FOLIC ACID | 1 | Unknown | 0 | 2.5 | MG | |||||||||
120437346 | 12043734 | 10 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
120437346 | 12043734 | 11 | C | CLAVULIN | AMOXICILLINCLAVULANIC ACID | 1 | Unknown | 0 | 550 | MG | |||||||||
120437346 | 12043734 | 12 | C | AMOXICILLIN. | AMOXICILLIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
120437346 | 12043734 | 1 | Rheumatoid arthritis |
120437346 | 12043734 | 7 | Gastritis |
120437346 | 12043734 | 8 | Pain |
120437346 | 12043734 | 9 | Anaemia |
120437346 | 12043734 | 10 | Arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
120437346 | 12043734 | OT |
120437346 | 12043734 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
120437346 | 12043734 | Blood cholesterol abnormal | |
120437346 | 12043734 | Blood cholesterol increased | |
120437346 | 12043734 | Cough | |
120437346 | 12043734 | Deafness | |
120437346 | 12043734 | Dizziness | |
120437346 | 12043734 | Ear disorder | |
120437346 | 12043734 | Eye pruritus | |
120437346 | 12043734 | Feeling hot | |
120437346 | 12043734 | Foot deformity | |
120437346 | 12043734 | Headache | |
120437346 | 12043734 | Hypersensitivity | |
120437346 | 12043734 | Impaired healing | |
120437346 | 12043734 | Influenza | |
120437346 | 12043734 | Ligament sprain | |
120437346 | 12043734 | Nasal congestion | |
120437346 | 12043734 | Nasal disorder | |
120437346 | 12043734 | Nasal pruritus | |
120437346 | 12043734 | Nasopharyngitis | |
120437346 | 12043734 | Nausea | |
120437346 | 12043734 | Oropharyngeal pain | |
120437346 | 12043734 | Pain | |
120437346 | 12043734 | Pain in extremity | |
120437346 | 12043734 | Pruritus | |
120437346 | 12043734 | Pruritus generalised | |
120437346 | 12043734 | Rhinitis | |
120437346 | 12043734 | Swelling | |
120437346 | 12043734 | Tendon disorder | |
120437346 | 12043734 | Thrombocytopenia | |
120437346 | 12043734 | Tinnitus | |
120437346 | 12043734 | Tooth disorder | |
120437346 | 12043734 | Tooth injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
120437346 | 12043734 | 1 | 20150303 | 0 |